Year: 2026
Type: preprint
Abstract: Infectious diseases remain a leading cause of global morbidity and mortality, while therapeutic discovery is hindered by fragmented biomedical data and antimicrobial resistance. To address this challenge, we developed the Infectious Disease Knowledge Graph (IDKG), a queryable platform that integrates curated chemical, biological, pharmacological, and clinical information relevant to infectious-disease drug discovery. Using a customized ORION pipeline, we integrated 20 data sources, including DrugCentral, SMACC, Heli-SMACC, NPASS, ClinicalTrials.gov, and host-virus interaction databases, into a Neo4j graph containing more than 4.6 million nodes and 26 million edges. IDKG supports graph-based reasoning through Clinical Outcome Pathways (COPs) and incorporates curation workflows for small molecules, biologics, and complex mixtures. Illustrative applications include reconstruction of a literature-supported remdesivir pathway for COVID-19 and graph-based mechanistic interpretation of experimentally observed quorum-sensing inhibitor-antibiotic synergies in multidrug-resistant bacteria. The platform provides an interoperable framework for drug repurposing, target prioritization, and mechanism-based hypothesis generation. IDKG is freely available at https://idkg.mml.unc.edu.
Institutions: University of North Carolina at Chapel Hill, Predictive, LLC
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: green
Award: G8336390816
OpenAlex ID: W7235012579
